Selected article for: "animal model and early stage"

Author: Xie, Xin-Hui; Wang, Xin-Luan; Yang, Hui-Lin; Zhao, De-Wei; Qin, Ling
Title: Steroid-associated osteonecrosis: Epidemiology, pathophysiology, animal model, prevention, and potential treatments (an overview)
  • Document date: 2015_1_13
  • ID: y6y235hw_18
    Snippet: The recent advance in understanding the pathophysiological mechanism of the inadequate repair at the early stage of SAON is on a decreased activity of BMSCs pool [13e15]. Steroids can induce differentiation of BMSCs into adipocytes linage by upregulating adipocytes transcription factor gene expression (Peroxisome proliferator-activated receptor gamma adipose-specific 422 and adipsin) and inhibit their osteogenic differentiation by downregulating .....
    Document: The recent advance in understanding the pathophysiological mechanism of the inadequate repair at the early stage of SAON is on a decreased activity of BMSCs pool [13e15]. Steroids can induce differentiation of BMSCs into adipocytes linage by upregulating adipocytes transcription factor gene expression (Peroxisome proliferator-activated receptor gamma adipose-specific 422 and adipsin) and inhibit their osteogenic differentiation by downregulating osteoblast transcription factor gene expression [Cbfa1/Runx2, type I collagen, bone morphogenetic protein (BMP-2), osteocalcin, osteopontin, and osteonectin, and osteocalcin], thus resulting in increased lipid deposition including larger fat cells number and its area fraction. Clinically, Gangji and Hernigou reported decreased number and osteogenic differentiation ability of BMSCs pool in iliac or femora in patients with SAON, which resulted in the inadequate lesion repair at early stage of ON [13e15]. The authors' group also demonstrated significantly increased lipid deposition including larger fat cells number and fat deposition area at the early stage of SAON in an animal model [9, 11, 16, 17] .

    Search related documents:
    Co phrase search for related documents
    • animal model and bone morphogenetic protein: 1, 2
    • animal model and decreased activity: 1, 2
    • animal model and decreased number: 1, 2
    • animal model and differentiation ability: 1
    • animal model and early stage: 1, 2, 3, 4, 5, 6, 7, 8
    • animal model and fat cell: 1
    • animal model and gene expression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • animal model and inadequate repair: 1
    • area fraction and decreased number: 1
    • area fraction and fat cell: 1
    • area fraction and fat deposition: 1
    • area fraction and fat deposition area: 1
    • bmsc differentiation and differentiation ability: 1
    • BMSCs pool and early stage: 1
    • bone morphogenetic protein and differentiation ability: 1
    • bone morphogenetic protein and gene expression: 1, 2, 3, 4
    • decreased activity and early stage: 1
    • decreased activity and gene expression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
    • decreased number and gene expression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11